Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Attenuated liver fibrosis in the absence of B cells
Tatiana I. Novobrantseva, … , Paula S. Hochman, Alexander Ibraghimov
Tatiana I. Novobrantseva, … , Paula S. Hochman, Alexander Ibraghimov
Published November 1, 2005
Citation Information: J Clin Invest. 2005;115(11):3072-3082. https://doi.org/10.1172/JCI24798.
View: Text | PDF
Research Article Immunology

Attenuated liver fibrosis in the absence of B cells

  • Text
  • PDF
Abstract

Analysis of mononuclear cells in the adult mouse liver revealed that B cells represent as much as half of the intrahepatic lymphocyte population. Intrahepatic B cells (IHB cells) are phenotypically similar to splenic B2 cells but express lower levels of CD23 and CD21 and higher levels of CD5. IHB cells proliferate as well as splenic B cells in response to anti-IgM and LPS stimulation in vitro. VDJ gene rearrangements in IHB cells contain insertions of N,P region nucleotides characteristic of B cells maturing in the adult bone marrow rather than in the fetal liver. To evaluate whether B cells can have an impact on liver pathology, we compared CCl4-induced fibrosis development in B cell–deficient and wild-type mice. CCl4 caused similar acute liver injury in mutant and wild-type mice. However, following 6 weeks of CCl4 treatment, histochemical analyses showed markedly reduced collagen deposition in B cell–deficient as compared with wild-type mice. By analyzing mice that have normal numbers of B cells but lack either T cells or immunoglobulin in the serum, we established that B cells have an impact on fibrosis in an antibody- and T cell–independent manner.

Authors

Tatiana I. Novobrantseva, Gerard R. Majeau, Aldo Amatucci, Sophia Kogan, Ian Brenner, Stefano Casola, Mark J. Shlomchik, Victor Koteliansky, Paula S. Hochman, Alexander Ibraghimov

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Phenotypic and functional characterization of IHB cells. (A) Lymphocytes...
Phenotypic and functional characterization of IHB cells. (A) Lymphocytes defined by their scatter (51) were stained with anti-IgD (x axis) and anti-IgM (y axis). Percentages of IgM+ and IgD+ cells are shown next to the gate. (B) The histograms compare the levels of CD21, CD23, and CD5 on CD19+ B cells from spleen, blood, PC, and liver. (C) Viability of CD19+ B cells from liver and spleen was assessed by staining with the DNA intercalating reagent 7AAD and annexin V (AnV); double-negative cells are viable. (D) Residual CFSE fluorescence intensity and CD86 levels in CFSE-labeled B cells from liver (upper panels) and spleen (lower panels) after 3.5 days of activation in the presence of different stimuli noted. NS, no stimulation.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts